Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108959232 | 10895923 | 2 | F | 20160823 | 20150307 | 20160823 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-013970 | BRISTOL MYERS SQUIBB | 34.00 | WK | Y | 0.00000 | 20160823 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108959232 | 10895923 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | UNK UNK, QD | U | 21436 | |||||||||
108959232 | 10895923 | 2 | SS | PAROXETINE. | PAROXETINE | 1 | Transplacental | U | 0 | ||||||||||
108959232 | 10895923 | 3 | SS | NORFLOXACIN | NORFLOXACIN | 1 | Transplacental | U | 0 | ||||||||||
108959232 | 10895923 | 4 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Transplacental | U | 0 | ||||||||||
108959232 | 10895923 | 5 | SS | CYAMEMAZINE | CYAMEMAZINE | 1 | Transplacental | U | 0 | ||||||||||
108959232 | 10895923 | 6 | SS | HALOPERIDOL. | HALOPERIDOL | 1 | Transplacental | U | 0 | ||||||||||
108959232 | 10895923 | 7 | SS | OXAZEPAM. | OXAZEPAM | 1 | Transplacental | U | 0 | ||||||||||
108959232 | 10895923 | 8 | SS | TETRAZEPAM | TETRAZEPAM | 1 | Transplacental | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
108959232 | 10895923 | 1 | Product used for unknown indication |
108959232 | 10895923 | 2 | Product used for unknown indication |
108959232 | 10895923 | 3 | Product used for unknown indication |
108959232 | 10895923 | 4 | Product used for unknown indication |
108959232 | 10895923 | 5 | Product used for unknown indication |
108959232 | 10895923 | 6 | Product used for unknown indication |
108959232 | 10895923 | 7 | Product used for unknown indication |
108959232 | 10895923 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
108959232 | 10895923 | CA |
108959232 | 10895923 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
108959232 | 10895923 | Congenital skin dimples | |
108959232 | 10895923 | Foetal exposure during pregnancy | |
108959232 | 10895923 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |